 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR...

Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific...

Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates

Strategic partnership expands Biognosys' services to include Alamar's NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys' DIA-MS unbiased...

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research Biognosys and Alamar Biosciences Forge Strategic Partnership in...

Blue Trust Inc. increased its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 14.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange...

Blue Trust Inc. Has $141,000 Stake in Bruker Co. (NASDAQ:BRKR)

Bruker Corporation (NASDAQ: BRKR) has been selected as the Instrument Business Outlook (IBO) Company of the Year for 2023. IBO cited Brukers double-digit organic revenue growth in 2023 in all major...

Bruker Selected as Company of the Year by Instrument Business Outlook

Legacy Wealth Asset Management LLC grew its holdings in Bruker Co. (NASDAQ:BRKR  Free Report) by 5.7% during the 4th quarter, according to the company in its most recent disclosure with the...

Legacy Wealth Asset Management LLC Has $251,000 Position in Bruker Co. (NASDAQ:BRKR)

Polar Capital Holdings Plc lessened its position in shares of Bruker Co. (NASDAQ:BRKR  Free Report) by 11.7% during the 3rd quarter, according to the company in its most recent disclosure with...

Bruker Co. (NASDAQ:BRKR) Shares Sold by Polar Capital Holdings Plc

At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The...

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

Bruker Co. (NASDAQ:BRKR  Free Report)  Equities research analysts at Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for shares of Bruker in a note issued to...

Bruker Co. (NASDAQ:BRKR) Expected to Earn Q2 2024 Earnings of $0.57 Per Share

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Günther Laukien in 1960 and is headquartered in Billerica, MA.

Volume (M)	572,961.00
52-Wk High	$94.86
52-Wk Low	$53.79

BRKR Bruker Corp

About

Feed

News

Sentiment

Earnings

Fundamentals